Sirolimus Oral Product

DRUG3 trials

Sponsors

University of Pennsylvania, Institute for Clinical and Experimental Medicine, Shanghai Children's Medical Center

Conditions

Diabetes Mellitus, Type 1Hemangioendothelioma of LiverLymphangioleiomyomatosisTuberous Sclerosis Complex

Phase 1

Safety of Simvastatin in LAM and TSC

CompletedNCT02061397

University of PennsylvaniaLymphangioleiomyomatosis, Tuberous Sclerosis Complex

Start: 2014-03-31End: 2019-12-13Updated: 2020-08-25

Phase 4

Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation

CompletedNCT03582878

Institute for Clinical and Experimental MedicineDiabetes Mellitus, Type 1

Start: 2004-01-01End: 2019-01-01Updated: 2021-04-26

Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)

Shanghai Children's Medical CenterHemangioendothelioma of Liver

Start: 2020-07-31End: 2025-06-30Target: 36Updated: 2020-05-29

Related Papers

Sirolimus vs mycophenolate mofetil (MMF) in primary combined pancreas and kidney transplantation. Results of a long-term prospective randomized study

American Journal of Transplantation2019-09-2814 citations